Mad Money: 2021年9月28日(火)の放送の要点

  • このトピックは空です。
0件の返信スレッドを表示中
  • 投稿者
    投稿
    • #11091
      暮眞★潤 (Jun Kurema)
      キーマスター

      2021年9月28日(火)放送のCNBC「Mad Money w/ Jim Cramer」のサマリーです。ビデオクリップ&トランスクリプト(英文)が掲載されているCNBCサイトへのリンクも併記しています。

       

      (1) Jim Cramer says he’s keeping new money ‘on the sidelines’ until the stock sell-off ends (https://www.cnbc.com/2021/09/28/jim-cramer-says-hes-keeping-new-money-on-the-sidelines-until-the-stock-sell-off-ends.html)

      • “At this point, it’s only safe to buy the stuff that’s been completely mauled or could be coiled springs,” CNBC’s Jim Cramer said Monday.
      • The “Mad Money” host said he believes eventually the stock market sell-off will “right itself.”
      • “I just think it’s worth waiting on the sidelines with new money until we figure out how things can turn around

      What’s behind the downturn?: (i) Accelerating inflation, (ii) Natural gas prices soaring, (iii) Supply chain nightmare, (iv) Covid-induced labor shortage, (v) Impact of infrastructure bill, (vi) Chip shortage

       

      (2) Executive Interview: Sonos CEO says this is the most challenging time he’s ever seen for tech companies (https://www.cnbc.com/video/2021/09/28/sonos-ceo-says-this-is-the-most-challenging-time-hes-ever-seen-for-tech-companies.html)

      Patrick Spence, the chief executive officer of Sonos, told “Mad Money” host Jim Cramer on Tuesday the tech industry in the most challenging period he’s ever seen.

      Ticker: SONO

       

      (3) Off-the-Chart: Charts suggest these four growth stocks are worth buying into weakness, says Jim Cramer (https://www.cnbc.com/2021/09/28/cramer-charts-suggest-these-4-stocks-are-worth-buying-into-weakness.html)

      • “The charts — as interpreted by Bob Lang — suggest that Affirm, Asana, Upstart and InMode are worth buying into weakness,” CNBC’s Jim Cramer said Tuesday.
      • “I’ve seen Lang make these calls before after monster sell-offs, and he’s been spot on,” the “Mad Money” host said.

      Ticker: AFRM, ASAN, UPST, INMO

       

      (4) Cramer says ‘steer clear’ of Warby Parker on public debut unless the stock trades at obvious discount (https://www.cnbc.com/2021/09/28/jim-cramer-says-to-steer-clear-of-warby-parker-on-public-debut.html)

      • CNBC’s Jim Cramer advised investors to be careful about buying shares of Warby Parker ahead of the eyeglass retailer’s scheduled direct listing Wednesday.
      • “I think you should steer clear of Warby Parker unless it falls below that [$40] reference price and you can get it in the $30s,” the “Mad Money” host said.

      Ticker: WRBY [The company will direct listing tomorrow]

       

      (5) Cramer’s lightning round: Cytokinetics is a very good speculative play (https://www.cnbc.com/2021/09/28/cramers-lightning-round-cytokinetics-is-a-very-good-speculative-play.html)

      • Cytokinetics: “This is early stage, and here’s what’s interesting about this company: Once again we find these companies that big pharma needs. This is a very good spec. Small molecule therapeutics. The big companies, the Pfizers, love these guys.”
      • LegalZoom.com: “I’ve been watching LZ. It’s going nowhere fast. It’s going nowhere fast. You can’t touch it. It has no backing on Wall Street, none whatsoever.”
      • Matterport: “3D cameras are very, very hot, but they’re too hot for me. I’m going to have to take a pass.”

      Ticker: CYTK, LZ, MTTR

       

      (6) [No Video Clip] Cramer’s take on labor shortage 

       

      Other Stocks Discussed (Calls with Audiences): GAP (GPS), Pfizer (PFE),  Snap (SNAP) [good shape]

       

      参考: この日の放送に関するその他のサイトへのリンク

      Disclaimer

      ****************************

      前回のエピソード 次回のエピソード

       

0件の返信スレッドを表示中
  • トピック「Mad Money: 2021年9月28日(火)の放送の要点」には新しい返信をつけることはできません。